Diagnostic value of EBV-DNA in CSF for PCNSL in AIDS patients with focal brain lesions: A meta-analysis of diagnostic test
Open Access
- 2 December 2022
- journal article
- review article
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (48) , e31793
Abstract
Background: Epstein-Barr virus (EBV) infection plays a crucial role in the progression of acquired immunodeficiency syndrome related primary central nervous system lymphoma (AR-PCNSL). This study aimed at evaluating the diagnostic value of cerebrospinal spinal fluid (CSF) EBV-deoxyribonucleic acid (DNA) for PCNSL in patients with infection of human immunodeficiency (HIV) virus through a meta-analysis of diagnostic test. Methods: A systematic search in PubMed, Embase, Web of Science, Wanfang, Chinese Biomedical Database and Chinese National Knowledge Infrastructure was conducted before May 10, 2022. Heterogeneity among the studies was assessed using Q test and I2 statistics. Publication bias was assessed using the Deek’s funnel plot asymmetry test. Statistical analyses were performed using Stata 16.0 software. The pooled sensitivity, specificity, positive and negative likelihood ratios (PLR and NLR), diagnostic odds ratios (DOR) and 95% confidence intervals (CI) were caculated to evaluate the diagnostic value. A symmetric receiver operating characteristic (SROC) curve and the area under the SROC curve (AUC) were constructed to evaluate the test-performance. Results: Twelve studies were included in the final analyses, with a total of 141 patients with AR-PCNSL and 590 controls. The pooled diagnostic values were sensitivity of 0.83 (95% CI: 0.73–0.90), specificity of 0.95 (95%CI: 0.89–0.98), PLR of 17.8 (95%CI: 6.8–46.1), NLR of 0.17 (95%CI: 0.10–0.30), DOR of 102 (95%CI: 28–379), and AUC of 0.94 (95%CI: 0.91–0.96). Conclusion: In summary the overall diagnostic value of CSF EBV-DNA is very high and it can be a reliable diagnostic biomarker for AR-PCNSL.Keywords
This publication has 27 references indexed in Scilit:
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy StudiesAnnals of Internal Medicine, 2011
- The predictive value of cerebrospinal fluid Epstein-Barr viral load as a marker of primary central nervous system lymphoma in HIV-infected personsJournal of Clinical Virology, 2008
- The significance of Epstein–Barr virus detected in the cerebrospinal fluid of people with HIV infectionHIV Medicine, 2007
- Positive Predictive Value of Epstein-Barr Virus DNA Detection in HIV-Related Primary Central Nervous System LymphomaClinical Infectious Diseases, 2004
- Predictive Value of Polymerase Chain Reaction of Cerebrospinal Fluid for Detection of Epstein-Barr Virus to Establish the Diagnosis of HIV-Related Primary Central Nervous System LymphomaClinical Infectious Diseases, 2004
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Advanced methods in meta‐analysis: multivariate approach and meta‐regressionStatistics in Medicine, 2002
- Polymerase chain reaction on cerebrospinal fluid for diagnosis of virus-associated opportunistic diseases of the central nervous system in HIV-infected patientsAIDS, 1996
- Evaluation of cerebrospinal fluid EBV‐DNA and IL‐10 as markers for in vivo diagnosis of AIDS‐related primary central nervous system lymphomaBritish Journal of Haematology, 1995
- Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous systemThe Lancet, 1993